10
Views
31
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Regulation of c-Fes Tyrosine Kinase and Biological Activities by N-Terminal Coiled-Coil Oligomerization Domains

, , &
Pages 8335-8343 | Received 09 Jul 1999, Accepted 19 Aug 1999, Published online: 28 Mar 2023

REFERENCES

  • Alexandropoulos, K., and J. Baltimore 1997. Coordinate activation of c-Src by SH3 and SH2 binding sites on a novel, p130Cas-related protein, Sin. Genes Dev. 10:1341–1355.
  • Briggs, S. D., M. Sharkey, M. Stevenson, and J. Smithgall 1997. SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J. Biol. Chem. 272:17899–17902.
  • Briggs, S. D., and J. Smithgall 1999. SH2-kinase linker mutations release Hck tyrosine kinase and transforming activities in rat-2 fibroblasts. J. Biol. Chem. 274:26579–26583.
  • Brown, M. T., and J. Cooper 1996. Regulation, substrates, and functions of Src. Biochim. Biophys. Acta 1287:121–149.
  • Erpel, T., G. Superti-Furga, and J. Courtneidge 1995. Mutational analysis of the Src SH3 domain: the same residues of the ligand binding surface are important for intra- and intermolecular interactions. EMBO J. 14:963–975.
  • Fang, F., S. Ahmad, J. Lei, R. W. Klecker, J. B. Trepel, T. E. Smithgall, and J. Glazer 1993. The effect of mutation of tyrosine 713 in p93c-fes on its catalytic activity and ability to promote myeloid differentiation in K-562 cells. Biochemistry 32:6995–7001.
  • Feldman, R. A., J. L. Gabrilove, J. P. Tam, M. A. S. Moore, and J. Hanafusa 1985. Specific expression of the human cellular fps/fes-encoded protein NCP92 in normal and leukemic myeloid cells. Proc. Natl. Acad. Sci. USA 82:2379–2383.
  • Feldman, R. A., D. R. Lowy, W. C. Vass, and J. Velu 1989. A highly efficient retroviral vector allows detection of the transforming activity of the human c-fps/fes proto-oncogene. J. Virol. 63:5469–5474.
  • Golub, T. R., A. Goga, G. F. Barker, D. E. H. Afar, J. McLaughlin, S. K. Bohlander, J. D. Rowley, O. N. Witte, and J. Gilliland 1996. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol. Cell. Biol. 16:4107–4116.
  • Gonfloni, S., J. C. Williams, K. Hattula, A. Weijland, R. K. Wierenga, and J. Superti-Furga 1997. The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src. EMBO J. 16:7261–7271.
  • Greer, P., J. Haigh, G. Mbamalu, W. Khoo, A. Bernstein, and J. Pawson 1994. The Fps/Fes protein-tyrosine kinase promotes angiogenesis in transgenic mice. Mol. Cell. Biol. 14:6755–6763.
  • Greer, P. A., K. Meckling-Hansen, and J. Pawson 1988. The human c-fps/fes gene product expressed ectopically in rat fibroblasts is nontransforming and has restrained protein-tyrosine kinase activity. Mol. Cell. Biol. 8:578–587.
  • Groffen, J., N. Heisterkamp, M. Shibuya, H. Hanafusa, and J. Stephenson 1983. Transforming genes of avian (v-fps) and mammalian (v-fes) retroviruses correspond to a common cellular locus. Virology 125:480–486.
  • Guo, X. Y., J. M. Cuillerot, T. Wang, Y. Wu, R. Arlinghaus, D. Claxton, C. Bachier, J. Greenberger, I. Colombowala, and J. Deisseroth 1998. Peptide containing the BCR oligomerization domain (AA 1–160) reverses the transformed phenotype of p210bcr-abl positive 32D myeloid leukemia cells. Oncogene 17:825–833.
  • Hampe, A., I. Laprevotte, F. Galibert, L. A. Fedele, and J. Sherr 1982. Nucleotide sequences of feline retroviral oncogenes (v-fes) provide evidence for a family of tyrosine-specific protein kinase genes. Cell 30:775–785.
  • Hanafusa, T., L.-H. Wang, S. M. Anderson, R. E. Karess, W. S. Hayward, and J. Hanafusa 1980. Characterization of the transforming gene of Fujinami sarcoma virus. Proc. Natl. Acad. Sci. USA 77:3009–3013.
  • Hanazono, Y., S. Chiba, K. Sasaki, H. Mano, A. Miyajima, K. Arai, Y. Yazaki, and J. Hirai 1993. c-fps/fes protein-tyrosine kinase is implicated in a signaling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3. EMBO J. 12:1641–1646.
  • Hanazono, Y., S. Chiba, K. Sasaki, H. Mano, Y. Yazaki, and J. Hirai 1993. Erythropoietin induces tyrosine phosphorylation and kinase activity of the c-fps/fes proto-oncogene product in human erythropoietin-responsive cells. Blood 81:3193–3196.
  • Huang, C.-C., C. Hammond, and J. Bishop 1984. Nucleotide sequence of v-fps in the PRC II strain of avian sarcoma virus. J. Virol. 50:125–131.
  • Izuhara, K., R. A. Feldman, P. Greer, and J. Harada 1994. Interaction of the c-fes proto-oncogene product with the interleukin-4 receptor. J. Biol. Chem. 269:18623–18629.
  • Kamps, M. P., J. E. Buss, and J. Sefton 1986. Rous sarcoma virus transforming protein lacking myristic acid phosphorylates known polypeptide substrates without inducing transformation. Cell 45:105–112.
  • Lee, W.-H., K. Bister, A. Pawson, T. Robins, C. Moscovici, and J. Duesberg 1980. Fujinami sarcoma virus: an avian RNA tumor virus with a unique transforming gene. Proc. Natl. Acad. Sci. USA 77:2018–2022.
  • Li, J., and J. Smithgall 1996. Co-expression with Bcr induces activation of the Fes tyrosine kinase and phosphorylation of specific N-terminal Bcr tyrosine residues. J. Biol. Chem. 271:32930–32936.
  • Li, J., and J. Smithgall 1998. Fibroblast transformation by Fps/Fes tyrosine kinases requires Ras, Rac and Cdc42 and induces extracellular signal-regulated and c-Jun N-terminal kinase activation. J. Biol. Chem. 273:13828–13834.
  • Lozzio, B. B., C. B. Lozzio, E. G. Bamberger, and J. Feliu 1981. A multipotential leukemia cell line (K-562) of human origin. Proc. Soc. Exp. Biol. Med. 166:546–550.
  • Lupas, A. 1996. Prediction and analysis of coiled-coil structures. Methods Enzymol. 266:513–525.
  • Lupas, A., M. Van Dyke, and J. Stock 1991. Predicting coiled coils from protein sequences. Science 252:1162–1164.
  • MacDonald, I., J. Levy, and J. Pawson 1985. Expression of the mammalian c-fes protein in hematopoietic cells and identification of a distinct fes-related protein. Mol. Cell. Biol. 5:2543–2551.
  • Maru, Y., K. L. Peters, D. E. H. Afar, M. Shibuya, O. N. Witte, and J. Smithgall 1995. Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS. Mol. Cell. Biol. 15:835–842.
  • Matsuda, T., T. Fukada, M. Takahashi-Tezuka, Y. Okuyama, Y. Fujitani, Y. Hanazono, H. Hirai, and J. Hirano 1995. Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association. J. Biol. Chem. 270:11037–1109.
  • McWhirter, J. R., D. L. Galasso, and J. Wang 1993. A coiled-coil oligomerization domain of bcr is essential for the transforming function of bcr-abl oncoproteins. Mol. Cell. Biol. 13:7587–7595.
  • Moarefi, I., M. LaFevre-Bernt, F. Sicheri, M. Huse, C.-H. Lee, J. Kuriyan, and J. Miller 1997. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385:650–653.
  • Muller, A. J., J. C. Young, A. M. Pendergast, M. Pondel, R. N. Landau, D. R. Littman, and J. Witte 1991. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol. 11:1785–1792.
  • Park, W.-Y., and J. Seo 1995. Leucine zipper-like domain regulates the autophosphorylation and the transforming activity of P130gag-fps. Biochem. Biophys. Res. Commun. 211:447–453.
  • Pear, W. S., G. P. Nolan, M. L. Scott, and J. Baltimore 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392–8396.
  • Read, R. D., J. M. Lionberger, and J. Smithgall 1997. Oligomerization of the Fes tyrosine kinase: evidence for a coiled-coil domain in the unique N-terminal region. J. Biol. Chem. 272:18498–18503.
  • Rogers, J. A., R. D. Read, J. Li, K. L. Peters, and J. Smithgall 1996. Autophosphorylation of the Fes tyrosine kinase: evidence for an intermolecular mechanism involving two kinase domain tyrosine residues. J. Biol. Chem. 271:17519–17525.
  • Shibuya, M., and J. Hanafusa 1982. Nucleotide sequence of Fujinami sarcoma virus: evolutionary relationship of its transforming gene with transforming genes of other sarcoma viruses. Cell 30:787–795.
  • Sicheri, F., I. Moarefi, and J. Kuriyan 1997. Crystal structure of the Src family tyrosine kinase Hck. Nature 385:602–609.
  • Smithgall, T. E., G. Yu, and J. Glazer 1988. Identification of the differentiation-associated p93 tyrosine protein kinase of HL-60 leukemia cells as the product of the human c-fes locus and its expression in myelomonocytic cells. J. Biol. Chem. 263:15050–15055.
  • Van Etten, R. A. 1999. Cycling, stressed-out and nervous: cellular functions of c-Abl. Trends Cell Biol. 9:179–186.
  • Weinmaster, G., M. J. Zoller, and J. Pawson 1986. A lysine in the ATP-binding site of P130gag-fps is essential for protein-tyrosine kinase activity. EMBO J. 5:69–76.
  • Weinmaster, G., M. J. Zoller, M. Smith, E. Hinze, and J. Pawson 1984. Mutagenesis of Fujinami sarcoma virus: evidence that tyrosine phosphorylation of p130gag-fps modulates its biological activity. Cell 37:559–568.
  • Williams, J. C., A. Weijland, S. Gonfloni, A. Thompson, S. A. Courtneidge, G. Superti-Furga, and J. Wierenga 1997. The 2.35 Å crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions. J. Mol. Biol. 274:757–775.
  • Xu, W., S. C. Harrison, and J. Eck 1997. Three-dimensional structure of the tyrosine kinase c-Src. Nature 385:595–602.
  • Yu, G., T. E. Smithgall, and J. Glazer 1989. K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation. J. Biol. Chem. 264:10276–10281.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.